Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2074.1%
Neutral622.2%
Bearish13.7%
FN2 Earnings Intelligence
MSCI Inc. (MSCI) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Sep 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 10, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 8, 2026 |
| UBS | Buy | Buy | Maintain | Apr 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Dec 18, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 12, 2024 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Oct 9, 2024 |
| Argus Research | Buy | Buy | Maintain | Jul 26, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Apr 24, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 9, 2024 |
| Redburn Partners | Neutral | Buy | Downgrade | Sep 14, 2023 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jul 17, 2023 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 8, 2020 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Feb 12, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 11, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 11, 2019 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 3, 2017 |
| Macquarie | Neutral | Neutral | Maintain | Feb 5, 2016 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Nov 10, 2015 |
| Keefe, Bruyette & Woods | Market Perform | Underperform | Upgrade | Nov 2, 2015 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Nov 2, 2015 |
| Janney Capital | Buy | Buy | Maintain | Dec 12, 2013 |
Upside is calculated against the persisted current price $562.65. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $722 | $569.86 | +28.3% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $690 | $561.74 | +22.6% | Jul 22, 2026 |
| UBS | Analyst unavailable | $615 | $561.74 | +9.3% | Jul 22, 2026 |
| Morgan Stanley | Toni Kaplan | $700 | $561.74 | +24.4% | Jul 21, 2026 |
| Barclays | Manav Patnaik | $735 | $603.35 | +30.6% | Jul 10, 2026 |
| Raymond James | Patrick O'Shaughnessy | $760 | $597.24 | +35.1% | Jul 8, 2026 |
| Redburn Partners | Analyst unavailable | $690 | $596.89 | +22.6% | Jun 18, 2026 |
| Wells Fargo | Jason Hass | $700 | $588.52 | +24.4% | May 27, 2026 |
| Raymond James | Patrick O'Shaughnessy | $730 | $589.17 | +29.7% | Apr 21, 2026 |
| Deutsche Bank | Analyst unavailable | $715 | $605.47 | +27.1% | Jan 29, 2026 |
| Evercore ISI | David Motemaden | $690 | $607.3 | +22.6% | Jan 29, 2026 |
| RBC Capital | Ashish Sabadra | $655 | $604.54 | +16.4% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $618 | $614.87 | +9.8% | Jan 29, 2026 |
| UBS | Analyst unavailable | $638 | $614.87 | +13.4% | Jan 28, 2026 |
| Raymond James | Patrick O'Shaughnessy | $690 | $586.47 | +22.6% | Jan 12, 2026 |
| UBS | Analyst unavailable | $710 | $593.76 | +26.2% | Oct 29, 2025 |
| UBS | Analyst unavailable | $601 | $593.76 | +6.8% | Oct 29, 2025 |
| Barclays | Manav Patnaik | $660 | $593.76 | +17.3% | Oct 29, 2025 |
| Seaport Global | Analyst unavailable | $650 | $567.41 | +15.5% | Oct 1, 2025 |
| Goldman Sachs | George Tong | $723 | $597.9 | +28.5% | Dec 18, 2024 |
| Goldman Sachs | George Tong | $617 | $578.93 | +9.7% | Oct 30, 2024 |
| Morgan Stanley | Toni Kaplan | $662 | $578.93 | +17.7% | Oct 29, 2024 |
| Barclays | Manav Patnaik | $700 | $559.75 | +24.4% | Sep 13, 2024 |
| Wells Fargo | Jason Haas | $570 | $532.41 | +1.3% | Aug 12, 2024 |
| Argus Research | John Eade | $600 | $544.6 | +6.6% | Jul 26, 2024 |
| UBS | Alex Kramm | $585 | $493 | +4.0% | Jul 9, 2024 |
| RBC Capital | Ashish Sabadra | $638 | $498.31 | +13.4% | Jun 6, 2024 |
| Goldman Sachs | George Tong | $526 | $503.83 | -6.5% | May 23, 2024 |
| Deutsche Bank | Faiza Alwy | $569 | $468.5 | +1.1% | Apr 24, 2024 |
| J.P. Morgan | Analyst unavailable | $585 | $561.94 | +4.0% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $543 | $538.02 | -3.5% | Feb 1, 2023 |
| RBC Capital | Analyst unavailable | $600 | $537.72 | +6.6% | Feb 1, 2023 |
| Oppenheimer | Analyst unavailable | $575 | $532.18 | +2.2% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $549 | $531.56 | -2.4% | Feb 1, 2023 |
| Raymond James | Patrick O'Shaughnessy | $539 | $505.24 | -4.2% | Jan 15, 2023 |
| Morgan Stanley | Analyst unavailable | $518 | $473.58 | -7.9% | Jan 4, 2023 |
| J.P. Morgan | Analyst unavailable | $580 | $522.87 | +3.1% | Dec 13, 2022 |
| Barclays | Analyst unavailable | $600 | $521.39 | +6.6% | Dec 2, 2022 |
| RBC Capital | Ashish Sabadra | $520 | $429.78 | -7.6% | Jun 28, 2022 |
| Barclays | Manav Patnaik | $470 | $416.71 | -16.5% | Jun 24, 2022 |
| Deutsche Bank | Analyst unavailable | $477 | $420.22 | -15.2% | Apr 27, 2022 |
| Barclays | Analyst unavailable | $570 | $422.42 | +1.3% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $540 | $424.62 | -4.0% | Apr 27, 2022 |
Track every rating change on MSCI the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.